The Value Science Foundation ™

Syenza Foundation is devoted to strengthening value based healthcare systems. We're a registered non-profit for nurturing independent thinking, market access research, and building social capital. We work with stakeholders across all segments of society to accelerate the diffusion of current and new healthcare technologies.

Work with Syenza Foundation

Some of the organizations our group has worked with.

What are our focus areas?

Independent Thinking

Value-based Health Care depends on an independent analysis of markets and new healthcare technologies.

Market Access Research

Value-based Health Care requires a new approach to market access research.

Building Social Capital

Value-based Health Care changes how we finance healthcare markets and build social capital for patients and broadly in society.

The Syenza Story

Syenza Foundation builds on our heritage at Syenza. Along the way we’ve learnt that accelerating value-based healthcare systems will require facilitating the exchange of knowledge and information. We’ve come a long way.

January 2008

Syenza starts consulting at WHO and Harvard Medical School

March 2011

Syenza accepts outsourced projects from prominent consulting firms

June 2015

Syenza strengthens its market access and pharmacoeconomics services for pain management and rare diseases.

September 2016

Syenza introduces its Client Chart and start working direct with top Clients

June 2017

Syenza's therapeutic area pharmacoeconomic projects cover cancer, CVD, rheumatoid arthritis, epilepsy, multiple sclerosis, HIV/AIDS.

April 2018

Syenza introduces the first fully online applied pharmacoeconomics course.

September 2019

A lot of miles implementing access projects, and delivered much analytics.

Since 2008, our group has ...

Travelled

4,928,768 km

implementing Access Projects

Written

1,252 p.

presenting our Analytic Work

Delivered

320 h

of Market Access Workshops

Exchanged Views in

21,384 min

of Global Conferencing

Our Team

Teresa

René

João

Althea

What stakeholders say about collaborating with our group?

Country Manager

Genzyme

Insight into proposed projects, and management of timelines and deliverables. Having articles on outcomes of the project once the project is completed.

Regional Market Access Manager

Boehringer Ingelheim

Self initiative to take the best path and overcome issues without seeking directions from us every time — saves everyone a lot of time and helps with timelines.

Senior Market Access Manager

Amgen

The collaborative efforts in defining the project, the discussions on the insights generated and follow-up and the further assistance that was offered in understanding the landscape.

Market Access Manager

Sanofi

The regular feedback and the commitment to timelines and delivery.

Global Public Affairs Director

Novo Nordisk

Dedicated and knowledgeable with a high interest in delivering value-adding outcomes.

Head of Market Access

Merck

Good insight into the market and new perspectives of looking at access.

Global Market Access Executive